Potential new therapy relieves chronic itch (Links to an external site)

Potential new therapy relieves chronic itch
The roots of chronic itching have long remained a mystery. Meanwhile, those with the condition suffer from an unrelenting and sometimes debilitating urge to scratch. Now, new research at Washington University School of Medicine in St. Louis has identified immune signaling molecules that are essential for activating neurons in the skin to cause chronic itching.

Gordon recipient of Massry Prize (Links to an external site)

Gordon recipient of Massry Prize
Jeffrey I. Gordon, MD, of Washington University School of Medicine in St. Louis, will share the 2017 Massry Prize with fellow microbiome researchers Norman Pace, PhD, of the University of Colorado Boulder, and Rob Knight, PhD, of the University of California San Diego.

Gordon receives Jacobæus Prize (Links to an external site)

Gordon receives Jacobæus Prize
Jeffrey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished University Professor at Washington University School of Medicine in St. Louis, has received the 2017 Jacobæus Prize from the Novo Nordisk Foundation for his role as the founding father of gut microbiome research.

Robyn Klein named vice provost and associate dean for graduate education for DBBS (Links to an external site)

Robyn S. Klein, MD, PhD, a physician-scientist recognized internationally for her work on the brain’s immune system, has been named vice provost and associate dean for graduate education for the Division of Biology & Biomedical Sciences (DBBS) at Washington University in St. Louis. She will begin her new post Jan. 1. Read the full story […]

Cancer drug may help patients with severe asthma

A new study co-authored by Mario Castro, MD, suggests a targeted cancer drug called imatinib (Gleevec) may help some patients with severe asthma who do not respond to standard therapy. Read the full story on the School of Medicine’s site »